Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CREATE-1: CRPS Treatment Evaluation 1 Study
2015-001527-22Phase 3Completed
- Sponsor
- Axsome Therapeutics, Inc.
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Complex Regional Pain Syndrome Type 1 (CRPS-1) comparing AXS-02 with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jul 2015; status: completed.
02
Drugs
zoledronate
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on 2015-001527-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001527-22.